Skip to main content
HR 3772 116th Congress House Health Drug therapy Health care costs and insurance Health technology, devices, supplies Home and outpatient care Medical tests and diagnostic methods Medicare

Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019

Introduced: July 16, 2019 Introduced by: Peters, Scott H. Democratic · California See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 17, 2019
Referred to the Subcommittee on Health.
Jul 16, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 16, 2019
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019

This bill establishes separate payment requirements for diagnostic radiopharmaceuticals under the Medicare prospective payment system for hospital outpatient department services. The bill's requirements apply to diagnostic radiopharmaceuticals that have an average daily cost of $500 or more in 2020 and as adjusted based on a specified fee schedule factor in each year thereafter.

What's happening now July 17, 2019

Referred to the Subcommittee on Health.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 3
 Cosponsors 17
All 17 Democratic 9 Republican 4
R
Reschenthaler, Guy
Pennsylvania · Sep 8, 2020
 D
Blunt Rochester, Lisa
Delaware · Jul 27, 2020
Walorski, Jackie
· Jul 16, 2020
 R
Murphy, Gregory F.
North Carolina · May 19, 2020
 D
Sewell, Terri A.
Alabama · Mar 11, 2020
 R
Rutherford, John H.
Florida · Feb 21, 2020
Brooks, Susan
· Jan 24, 2020
 D
Watson Coleman, Bonnie
New Jersey · Dec 16, 2019
 D
Krishnamoorthi, Raja
Illinois · Nov 29, 2019
 D
Moulton, Seth
Massachusetts · Nov 8, 2019
 D
Slotkin, Elissa
Michigan · Nov 8, 2019
 D
Soto, Darren
Florida · Nov 8, 2019
Loebsack, David
· Oct 31, 2019
 R
Burchett, Tim
Tennessee · Oct 22, 2019
 D
McGovern, James P.
Massachusetts · Sep 20, 2019
 D
Lieu, Ted
California · Sep 6, 2019
Holding, George
· Jul 16, 2019
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 3772: Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019. 116th Congress. Open America. https://openamerica.io/bill/116-HR-3772/
MLA
"H.R. 3772: Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-3772/.
Bluebook (legal)
H.R. 3772, 116th Cong. (2026), https://openamerica.io/bill/116-HR-3772/.
Markdown link
[H.R. 3772: Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019](https://openamerica.io/bill/116-HR-3772/)
Report a problem